The Advanced Therapies Congress features speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma, biotech and startup companies, researchers, clinicians, academics, HTAs, payers, regulators.
With 8 tracks of content, the agenda covered everything from manufacturing, supply chain & logistics, pricing & market access, to developments in key therapeutic areas. This included cell therapy, gene therapy, gene modified cell therapy, gene editing, stem cells and regenerative medicine, and much more.
